ALSUntangled No. 36: Accilion.
Publication
, Journal Article
ALSUNTANGLED GROUP,
Published in: Amyotroph Lateral Scler Frontotemporal Degener
February 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Amyotroph Lateral Scler Frontotemporal Degener
DOI
EISSN
2167-9223
Publication Date
February 2017
Volume
18
Issue
1-2
Start / End Page
142 / 147
Location
England
Related Subject Headings
- Treatment Outcome
- Risk
- Humans
- Clinical Trials as Topic
- Animals
- Amyotrophic Lateral Sclerosis
- 3209 Neurosciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
ALSUNTANGLED GROUP, . (2017). ALSUntangled No. 36: Accilion. Amyotroph Lateral Scler Frontotemporal Degener, 18(1–2), 142–147. https://doi.org/10.1080/21678421.2016.1215400
ALSUNTANGLED GROUP, Hiroshi. “ALSUntangled No. 36: Accilion.” Amyotroph Lateral Scler Frontotemporal Degener 18, no. 1–2 (February 2017): 142–47. https://doi.org/10.1080/21678421.2016.1215400.
ALSUNTANGLED GROUP. ALSUntangled No. 36: Accilion. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1–2):142–7.
ALSUNTANGLED GROUP, Hiroshi. “ALSUntangled No. 36: Accilion.” Amyotroph Lateral Scler Frontotemporal Degener, vol. 18, no. 1–2, Feb. 2017, pp. 142–47. Pubmed, doi:10.1080/21678421.2016.1215400.
ALSUNTANGLED GROUP. ALSUntangled No. 36: Accilion. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1–2):142–147.
Published In
Amyotroph Lateral Scler Frontotemporal Degener
DOI
EISSN
2167-9223
Publication Date
February 2017
Volume
18
Issue
1-2
Start / End Page
142 / 147
Location
England
Related Subject Headings
- Treatment Outcome
- Risk
- Humans
- Clinical Trials as Topic
- Animals
- Amyotrophic Lateral Sclerosis
- 3209 Neurosciences
- 1109 Neurosciences
- 1103 Clinical Sciences